08:00 , Dec 16, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Neuroendocrine tumors LIM domain only 1 (LMO1) In vitro and genetic studies identified LMO1 variants that could help predict neuroblastoma aggressiveness....